Low‐cost protocol for the production of autologous serum eye drops by blood collection and processing centres for the treatment of ocular surface diseases

Abstract

Efforts should be made to propagate a similar protocol for the production of ASEs in blood centres capable of collecting and processing blood products, making this service affordable and uniformly accessible to patients.